Form 4 Filing for Candel Therapeutics, Inc. - Insider Transaction

This filing details a Form 4 submission for Candel Therapeutics, Inc. (CADL), reporting an insider transaction by Paul B. Manning. On June 23, 2026, Manning acquired 32,000 stock options with a right to buy Common Stock. These options have a $0.00 transaction price and are subject to time-based vesting. The shares underlying the option will vest upon the earlier of June 23, 2027, or the next Annual Meeting of Stockholders, provided Manning remains a director. The option has an exercise price of $9.08 and expires on June 23, 2036. Manning, who is a director, acquired these options subsequent to the reporting period, with the filing dated June 24, 2026.